Sally Beauty Holdings (NYSE: SBH) holder plans 15,000-share Rule 144 sale
Rhea-AI Filing Summary
A holder of Sally Beauty Holdings common stock filed a notice to sell 15,000 shares under Rule 144 through UBS Financial Services Inc., with an approximate sale date of December 1, 2025 on the NYSE.
The filing lists an aggregate market value of $244,050 for these shares and notes that 97,497,664 common shares are outstanding. The seller acquired the stock mainly through restricted stock awards and restricted stock unit vesting between September 2021 and November 2022, with cash listed as the form of payment at vesting.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for SBH disclose?
The Form 144 discloses that a holder of Sally Beauty Holdings (SBH) common stock intends to sell 15,000 shares of common stock under Rule 144 through UBS Financial Services Inc., with trading expected on the NYSE.
How many Sally Beauty Holdings (SBH) shares are planned to be sold and at what value?
The notice covers a planned sale of 15,000 common shares of Sally Beauty Holdings with an indicated aggregate market value of $244,050.
On which exchange will the SBH shares in this Form 144 be sold?
The filing states that the 15,000 common shares of Sally Beauty Holdings are to be sold on the NYSE.
Who is the broker for the SBH Rule 144 share sale?
The broker named for this planned sale of 15,000 SBH common shares is UBS Financial Services Inc., 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086.
How many Sally Beauty Holdings (SBH) shares are outstanding according to this notice?
The Form 144 lists 97,497,664 common shares of Sally Beauty Holdings as outstanding at the time of the filing.
How were the SBH shares in this Form 144 acquired?
The shares were acquired through restricted stock awards and restricted stock unit vesting from Sally Beauty Holdings in 2021 and 2022, with cash shown as the nature of payment at vesting.
What representation does the seller make in the SBH Form 144?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.